Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Non-Hodgkin Lymphoma (All Stages^), 2017-2021

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Recent Trends - This is an interpretation of the AAPC/APC:

AAPC/APC (95% Confidence Interval) - the change in rate over time


Other Notes


Line by Line Interpretation of the Report


US (SEER+NPCR)1


Puerto Rico6


New Mexico7


Alabama6


Nevada6


Arizona6


Hawaii7


District of Columbia6


South Carolina6


Wyoming6


Mississippi6


Virginia6


Colorado6


Delaware6


Tennessee6


Oklahoma6


Georgia7


Arkansas6


Maryland6


Montana6


Texas7


California7


Alaska6


Oregon6


North Carolina6


Missouri6


Rhode Island6


Michigan6


Kansas6


Massachusetts7


Utah7


Vermont6


Idaho7


Illinois7


Louisiana7


Washington5


Ohio6


South Dakota6


Pennsylvania6


North Dakota6


Nebraska6


West Virginia6


Maine6


Kentucky7


New Hampshire6


New York7


Wisconsin6


Connecticut7


New Jersey7


Iowa7


Florida6


Minnesota6


Indiana6

Notes:
Created by statecancerprofiles.cancer.gov on 04/29/2025 8:16 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) Summary/Historic Combined Summary Stage (2004+).
Data not available for this combination of data selections.
Source: SEER and NPCR data. For more specific information please see the table.

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.